Download the Complete Report Here By Brandon Hornback Aurora Cannabis Inc. (NASDAQ: ACB) smoked another quarter, led by top-line growth, profitability, and disciplined capital allocation. And in fresh news, there’s positive cash flow right around the corner. Take a hit off this: The top line increased 11%, driven primarily by strong medical cannabis performance linked to high demand from Germany, Poland, and Australia. Gross margin expanded significantly to 61%, led by the medical business, which continue ...

We also offer income-focused picks for those who prefer lower-risk firms with steady dividend payouts. Our 10-year track record proves the ability of our analyst team to outperform across all market conditions.Value Investor's Edge provides the world's best energy, shipping, and offshore market research. Over the past decade, we have achieved an annualized return of almost 40% with a long-only model portfolio return of over 23x.I have covered Aurora Cannabis Inc. or "Aurora Cannabis" ( ACB , ACB:CA ) previo ...

Group 1 - The analyst team has a proven track record of outperforming across all market conditions, achieving an annualized return of almost 40% over the past decade with a long-only model portfolio return of over 23x [1] - The focus includes income-oriented picks for investors preferring lower-risk firms with steady dividend payouts [1] - The research covers sectors such as energy, shipping, and offshore markets, indicating a broad scope of industry analysis [1] Group 2 - Aurora Cannabis Inc. is mentioned as a company previously covered, indicating ongoing interest and updates regarding its performance [2] - The analyst has expanded coverage to include offshore drilling, supply industry, and shipping, alongside a focus on the fuel cell industry [3] - The analyst has a background in auditing and trading, providing a diverse perspective on market movements and industry trends [3]

Like an oasis in the desert, this morning’s Automatic Data Processing (ADP) private-sector payroll report for October is out ahead of today’s opening bell. If these were regular times, this would merely be the latest piece of data in a full Jobs Week. As it is, this may be the only jobs report we get until the government reopens.ADP Improves on Large-Firm Hiring: +42KOctober ADP private-sector jobs numbers posted a headline of +42K new positions filled. This is an improvement of +20K above expectations and ...

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [1][2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [2][3] - Proactive focuses on various sectors including biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Group 2 - Proactive is committed to adopting technology to enhance workflows and content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]

Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +200.00%. A quarter ago, it was expected that this company would post earnings of $0.18 per share when it actually produced a loss of $0.19, delivering a surprise of -205.56%.Over the last four quarters, the co ...

Aurora Cannabis (NasdaqCM:ACB) Q2 2026 Earnings Call November 05, 2025 08:00 AM ET Speaker5Greetings and welcome to Aurora Cannabis Fiscal Second Quarter 2026 Results Conference Call. All participants will be in a listen only mode. A question and answer session will follow the formal presentation. The conference is being recorded today, Wednesday, November 5, 2025. I would now like to turn the conference over to your host, Simona King, Chief Financial Officer, Aurora Cannabis. Please go ahead.Speaker4Hello ...

INVESTOR PRESENTATION FY26 Q2 November 2025 Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information contained in this presentation constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this presentation that are not statements of historical fact may be deemed to be forward-looking statements. Forward looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "in ...

Accessibility StatementSkip Navigation NASDAQ | TSX: ACB EDMONTON, AB, Nov. 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter 2026 period ending September 30, 2025. "Aurora's quarterly performance highlights our continued focus on profitable growth. We achieved record net revenue for global medical cannabis representing a 15% ye ...

Core Insights - The Canadian cannabis market is evolving with global demand increasing and U.S. legalization being a significant topic of interest [1][13] - Major producers are focusing on profitability, cost reduction, and high-margin opportunities like medical exports and branded products [1][13] Company Summaries Tilray Brands, Inc. (TLRY) - Tilray is expanding its U.S. presence through hemp-derived THC beverages and wellness products, focusing on consumer engagement and product innovation [3][5] - For fiscal 2025, Tilray's total net revenue increased by approximately 4% year over year to over $820 million, with gross profit in its cannabis division rising to nearly $100 million and gross margin expanding from 33% to 40% [5][12] - Despite facing a net loss due to impairment charges, management is confident in its restructuring plan and international expansion strategy [5][12] Cronos Group Inc. (CRON) - Cronos is focused on innovation and cannabinoid research, preparing for potential federal legalization in the U.S. while serving international medical and wellness markets [7][9] - In 2024, Cronos's annual net revenue rose by over 30%, with quarterly results in early 2025 showing continued progress and net income turning positive for the first time in years [9][12] - The company maintains a strong balance sheet with substantial cash reserves and minimal debt, positioning itself for sustained growth [9][12] Aurora Cannabis Inc. (ACB) - Aurora serves both medical and recreational markets across more than 25 countries, focusing on medical exports and high-quality production [10][12] - The company reported over 35% year-over-year revenue growth in 2025, with medical cannabis sales rising over 50% [12] - Aurora's strategic pivot towards the higher-margin medical market has improved profitability and stabilized cash flow, positioning it well for future growth [12][13] Industry Outlook - The Canadian cannabis sector is navigating a critical transformation period, with companies like Tilray, Cronos, and Aurora leading the charge [13][14] - Investors are encouraged to monitor technical patterns and apply strict risk management to capitalize on potential growth opportunities in November 2025 [14]